Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

647 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum to: Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ. Guitart J, et al. Among authors: salazar r. Clin Drug Investig. 2016 Aug;36(8):695. doi: 10.1007/s40261-016-0416-9. Clin Drug Investig. 2016. PMID: 27256618 No abstract available.
Efficacy and safety of sublingual fentanyl orally disintegrating tablets in patients with breakthrough pain: multicentre prospective study.
Guitart J, Vargas I, De Sanctis V, Ferreras J, Fuentes J, Salazar R, Vázquez JM, Folch J, Moya J, Ribera H, Rodelas F, Tomás A, Arilla M, Coma J, Aberasturi T, Sintes D, Lombán E. Guitart J, et al. Among authors: salazar r. Clin Drug Investig. 2013 Sep;33(9):675-83. doi: 10.1007/s40261-013-0111-z. Clin Drug Investig. 2013. PMID: 23881567 Clinical Trial.
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. Guitart J, et al. Among authors: salazar r. Drugs R D. 2018 Jun;18(2):119-128. doi: 10.1007/s40268-018-0231-2. Drugs R D. 2018. PMID: 29572732 Free PMC article.
Correction to: Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. Guitart J, et al. Among authors: salazar r. Drugs R D. 2018 Sep;18(3):247-248. doi: 10.1007/s40268-018-0239-7. Drugs R D. 2018. PMID: 29987670 Free PMC article.
S100A1ct: A Synthetic Peptide Derived From S100A1 Protein Improves Cardiac Performance and Survival in Preclinical Heart Failure Models.
Kehr D, Ritterhoff J, Glaser M, Jarosch L, Salazar RE, Spaich K, Varadi K, Birkenstock J, Egger M, Gao E, Koch WJ, Sauter M, Freichel M, Katus HA, Frey N, Jungmann A, Busch C, Mather PJ, Ruhparwar A, Busch M, Völkers M, Wade RC, Most P. Kehr D, et al. Among authors: salazar re. Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.123.066961. Online ahead of print. Circulation. 2024. PMID: 39569500 Free article.
Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ Transplants.
Moeller CM, Oren D, Fernandez Valledor A, Rubinstein G, Lotan D, Mehlman Y, Slomovich S, Rahman S, Lee C, Baranowska J, Regan M, Elad B, DeFilippis EM, Hennecken C, Salazar R, Raikhelkar J, Clerkin KJ, Fried J, Lin E, Bae D, Oh KT, Latif F, Topkara VK, Naka Y, Takeda K, Majure D, Uriel N, Sayer G. Moeller CM, et al. Among authors: salazar r. Clin Transplant. 2024 Oct;38(10):e15479. doi: 10.1111/ctr.15479. Clin Transplant. 2024. PMID: 39422086
647 results